Smith & Nephew plc (SNN,SN.L) Wednesday announced an agreement to acquire Fort Worth, Texas based Healthpoint Biotherapeutics for an all-cash offer of $782 million.
Healthpoint is engaged in the development and commercialisation of novel, cost-effective bioactive solutions for skin repair and regeneration. Smith & Nephew intends to build upon Healthpoint's complementary product range and established commercial organisation, thereby strengthening its position in the U.S.
Upon close of acquisition, Healthpoint will be integrated into Smith & Nephew's Advanced Wound Management division.
The purchase price of $782 million in cash is being financed from the company's existing cash resources and bank facilities.
"The acquisition reinforces our Advanced Wound Management division by giving us a strong position in the fast growing area of bioactive wound care treatment. It brings material revenues from a fast growing product range, an attractive pipeline, and commercial and R&D capabilities upon which we will build, " said Olivier Bohuon, CEO of Smith & Nephew.
Healthpoint is expected to generate around $190 million sales in 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.